All articles tagged with #sleep medicine
A European phase II trial with 240 adults showed that nightly 200–300 mg sulthiame reduced sleep-apnea severity by about 30–50% versus placebo, improving breathing interruptions and oxygenation with no major safety concerns. The results suggest a direct pharmacological approach to sleep-disordered breathing, though longer and broader studies are needed to confirm durability and safety beyond CPAP-centered care.
A small two-night, placebo-controlled study at a sleep clinic with 38 healthy adults aged 45–65 found that suvorexant reduced cerebrospinal fluid amyloid-beta by 10–20% and temporarily lowered some forms of tau, even though there were no sleep differences between groups. The results suggest a link between promoting sleep and Alzheimer's biomarkers, but researchers caution against using sleeping pills as a preventive strategy without longer, larger trials and acknowledge potential downsides of long-term use.
Artificial intelligence is revolutionizing sleep medicine by enhancing clinical applications, lifestyle management, and population health. AI-powered devices and algorithms can monitor sleep patterns, diagnose disorders, offer personalized recommendations, predict issues, create smart sleep environments, and integrate mental health insights. While AI can improve sleep quality and reduce physician burnout, experts caution that it should complement, not replace, clinical expertise and emphasize the need for ethical considerations and patient privacy.